ACCESS Newswire
12 May 2022, 11:55 GMT+10
GOTHENBURG, SE / ACCESSWIRE / May 12, 2022 / XVIVO Perfusion AB (STO:XVIVO) (LSE:0RKL) (FRA:3XV)
Machine perfusion for lungs and livers is now being reimbursed in the Dutch healthcare system. The Netherlands has a pronounced evidence-based healthcare system. Therefore, if a treatment option is proven beneficial for patients the government is likely to approve reimbursement. Several clinical trials conducted by world-renowned clinicians served as a foundation for the Dutch Ministry of Health's decision. XVIVO's technologies were used in those clinical trials.
Reducing post-transplant complications is an important objective for every transplant team. Combining traditional static cold preservation with machine perfusion before transplantation has shown to improve organ quality and thereby increase patient well-being. In a recent article in NEJM[1], using the dHOPE protocol with XVIVO's machine perfusion technology for DCD (Donation after Circulatory Death) livers demonstrated a decrease in post-transplant complications.
'Machine perfusion for kidneys was already reimbursed in the Netherlands, and now it makes me very happy that also lungs and livers are included. XVIVO's machine perfusion technology for lungs has been on the Dutch market for 8 years and is used at all lung transplant centers. The perfusion technology for livers has been available for 10 years and is used at every liver transplant center throughout the country' says Mark Slotemaker, Regional Business Manager Abdominal, Benelux and DACH, XVIVO.
'Patients always deserve the best. By countries widening their reimbursement systems more patients can get a lifesaving transplant. XVIVO's technologies for machine perfusion have on many occasions proven to be one of the important reasons behind countries broadening their reimbursement criteria, which makes me very proud. We come to work every day because ‘nobody should die waiting for a new organ', and therefore I am very pleased to see the positive development in the Netherlands', says Dag Andersson, CEO of XVIVO.
Dag Andersson, CEO
XVIVO Perfusion AB (publ)
[1] van Rijn R, et al. Hypothermic Machine Perfusion in Liver Transplantation - A Randomized Trial. N Engl J Med. 2021; 384:1391-1401.
For further information, please contact:
Dag Andersson, CEO, +46 76 643 30 31, e-mail: [email protected]
Kristoffer Nordström, CFO, +46 73 519 21 64, e-mail: [email protected]
About Us
Founded in 1998, XVIVO is the only medical technology company dedicated to extending the life of all major organs - so transplant teams around the world can save more lives. Our solutions allow leading clinicians and researchers to push the boundaries of transplantation medicine. XVIVO is headquartered in Gothenburg, Sweden, and has offices and research sites on two continents. The company is listed on Nasdaq and has the ticker symbol XVIVO. More information can be found on the website www.xvivogroup.com.
Attachments
SOURCE: XVIVO Perfusion AB
Get a daily dose of Nashville Herald news through our daily email, its complimentary and keeps you fully up to date with world and business news as well.
Publish news of your business, community or sports group, personnel appointments, major event and more by submitting a news release to Nashville Herald.
More InformationIn the past month alone, 23 Israeli soldiers have been killed in Gaza—three more than the number of remaining living hostages held...
LONDON, U.K.: At least 13 people are believed to have taken their own lives as a result of the U.K.'s Post Office scandal, in which...
WASHINGTON, D.C.: Travelers at U.S. airports will no longer need to remove their shoes during security screenings, Department of Homeland...
WASHINGTON, D.C.: An elaborate impersonation scheme involving artificial intelligence targeted senior U.S. and foreign officials in...
SLUBICE, Poland: Poland reinstated border controls with Germany and Lithuania on July 7, following Germany's earlier reintroduction...
WASHINGTON, D.C.: After months of warnings from former federal officials and weather experts, the deadly flash floods that struck the...
WASHINGTON, D.C.: A federal rule designed to make it easier for Americans to cancel subscriptions has been blocked by a U.S. appeals...
BASTROP, Texas: In a surprising turn at Elon Musk's X platform, CEO Linda Yaccarino announced she is stepping down, just months after...
NEW YORK CITY, New York: Former British prime minister Rishi Sunak will return to Goldman Sachs in an advisory role, the Wall Street...
LONDON, U.K.: Physically backed gold exchange-traded funds recorded their most significant semi-annual inflow since the first half...
AMSTERDAM, Netherlands: Some 32 percent of global semiconductor production could face climate change-related copper supply disruptions...
NEW YORK, New York - U.S. stocks rebounded Tuesday with all the major indices gaining ground. Markets in the UK, Europe and Canada...